Oral lichen planus (OLP) is classified as a T-cell mediated autoimmune disease. The immune system’s own white blood cells attack the lining of the mouth, destroying cells in the deepest layer of the oral tissue. It affects roughly 1% of the global population, most commonly appearing in middle-aged adults between 50 and 60 years old, and is rare in children.
How the Immune System Attacks the Mouth
In OLP, a specific type of immune cell called a CD8+ T cell (sometimes referred to as a “killer” T cell) migrates into the oral tissue and triggers the self-destruction of basal keratinocytes, the foundational cells that anchor the mouth’s inner lining. This isn’t a response to an outside invader like a virus or bacteria. The immune system treats normal mouth tissue as a threat.
The process works through a chain reaction. Helper T cells release signaling molecules, including interferon gamma and interleukin-2, that activate the killer T cells. Once activated, those killer T cells destroy basal cells through several pathways, including releasing a protein called TNF-alpha and activating a self-destruct signal in the targeted cells. Other inflammatory signals, including interleukin-1, keep the process going by drawing more immune cells to the area. This creates the chronic, recurring inflammation that defines the condition.
What It Looks and Feels Like
OLP has six recognized clinical forms: reticular, atrophic, erosive, papular, plaque, and bullous. Many of these patterns show up at the same time or shift from one form to another over time.
The most characteristic sign is a network of intersecting white lines, called Wickham striae, on the inner cheeks. In some ethnic groups these lines can appear pigmented rather than white. The reticular form often causes no pain and may be discovered during a routine dental exam. The plaque form tends to appear on the tongue and is more common in smokers.
Erosive and atrophic forms are the ones that cause the most trouble. Erosive OLP produces open sores that can make eating, drinking, and brushing teeth painful. When ulceration is severe, the characteristic white lines may be hidden beneath the raw tissue, making diagnosis harder without a biopsy. The atrophic form creates red, thinned patches that burn or sting, particularly when exposed to spicy or acidic foods.
How It’s Diagnosed
Diagnosis usually requires both a clinical exam and a biopsy. Under a microscope, the hallmark findings include a dense band of immune cells attacking the junction between the surface layer and the deeper tissue, degeneration of the basal cell layer, and a sawtooth pattern in the tissue ridges. Small round structures called colloid bodies, which are remnants of destroyed cells, are also typical.
A special staining test called direct immunofluorescence can support the diagnosis. In OLP, it shows a characteristic “shaggy” deposit of a clotting protein called fibrinogen along the basement membrane, the boundary between the surface and deeper layers of tissue. Notably, the common immune proteins (IgG, IgA, IgM) are absent in OLP, which helps distinguish it from other conditions like pemphigoid that also cause mouth sores.
Conditions That Look Similar
Certain medications and dental materials can produce sores in the mouth that look nearly identical to OLP. These are called oral lichenoid reactions, and distinguishing them matters because removing the trigger can resolve the problem entirely.
The most commonly implicated dental material is amalgam (silver fillings). Among medications, NSAIDs and ACE inhibitors (a type of blood pressure drug) are the most frequent culprits, followed by antimalarials, diuretics, oral diabetes medications, and beta blockers. If your mouth sores appeared shortly after starting a new medication or getting dental work, that timing is worth mentioning to your dentist or doctor. High-end dental materials like titanium and zirconium have not been linked to these reactions.
The Hepatitis C Connection
One of the strongest and most consistent associations with OLP is hepatitis C infection. Across multiple studies, patients with OLP are three to nine times more likely to have hepatitis C antibodies than the general population. In one large study, 29% of OLP patients tested positive for hepatitis C compared to just 3% of controls. The rates vary by region: roughly 26% in Italy, 19% in Spain, and about 6% in Turkey.
The relationship also runs in the other direction. When researchers examined patients already known to have hepatitis C during routine dental checkups, 20% showed clinical signs of OLP. This overlap is strong enough that some clinicians recommend hepatitis C screening for newly diagnosed OLP patients, particularly in regions where the virus is more common. Hepatitis C infection also increases the risk of OLP progressing to cancer.
Cancer Risk
OLP is considered a potentially premalignant condition. The malignant transformation rate ranges from 0.44% to 2.28%, with a large meta-analysis placing the overall figure at about 1.1% of OLP lesions progressing to oral squamous cell carcinoma. That risk is low in absolute terms but meaningful over a lifetime of living with a chronic condition.
Smokers, heavy alcohol users, and people with hepatitis C face higher risk. This is why long-term monitoring is standard for anyone with OLP, typically involving periodic oral exams to catch any tissue changes early. The erosive form, because it involves ongoing tissue damage and repair, generally warrants closer surveillance than the painless reticular form.
Treatment and What to Expect
There is no cure for OLP. Treatment focuses on controlling flare-ups, reducing pain, and protecting the tissue from further damage. Topical corticosteroids applied directly to the affected areas are the first-line treatment for erosive and symptomatic forms. These are typically used as gels or rinses applied several times a day during active flares.
Among the topical options, fluocinolone acetonide has shown better results than triamcinolone acetonide in comparative studies, with roughly two-thirds of patients achieving clearance versus less than half with the alternative. For thickened, stubborn patches, corticosteroid injections directly into the lesion are sometimes used. Some clinicians recommend applying the topical treatment under a covering overnight to improve absorption.
The reticular form, when painless, often requires no treatment beyond monitoring. For the erosive form, most people go through cycles of flares and remission. Avoiding known irritants, including spicy foods, rough or crunchy textures, alcohol-based mouthwashes, and acidic drinks, can reduce how often and how intensely flares occur. Good oral hygiene also matters, since plaque buildup and gum disease can worsen symptoms in affected areas.